Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Capital Expenditures (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Capital Expenditures came in at $198.0 million in Q2 2026, up 31.13% year-over-year from $151.0 million in Q2 2025, and up 55.91% quarter-over-quarter from $127.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Capital Expenditures (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Capital Expenditures across 15 years of filings, most recently posting $198.0 million for Q2 2026.

  • In Q2 2026, Capital Expenditures rose 31.13% year-over-year to $198.0 million; the TTM figure through Jun 2026 stood at $635.0 million (up 4.61% YoY), while the FY2025 annual figure was $603.0 million, changed 0.17% from the prior year.
  • Capital Expenditures came in at $198.0 million for Q2 2026 at Iqvia Holdings, up from $127.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $198.0 million in Q2 2026 to a low of $127.0 million in Q1 2026.
  • Average Capital Expenditures over 5 years is $158.5 million, with a median of $160.5 million recorded in 2022.
  • Year-over-year, Capital Expenditures declined 11.59% in 2024 and surged 31.13% in 2026.
  • Over 5 years, Capital Expenditures stood at $171.0 million in 2022, then climbed by 4.68% to $179.0 million in 2023, then decreased by 8.38% to $164.0 million in 2024, then climbed by 6.1% to $174.0 million in 2025, then gained by 13.79% to $198.0 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $198.0 million in Q2 2026, $127.0 million in Q1 2026, and $174.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 23.91 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -42.42 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 31.11 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 9.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 2.62 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 125,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198.00 Mn
Mar 31, 2026 127.00 Mn
Dec 31, 2025 174.00 Mn
Sep 30, 2025 136.00 Mn
Jun 30, 2025 151.00 Mn
Mar 31, 2025 142.00 Mn
Dec 31, 2024 164.00 Mn
Sep 30, 2024 150.00 Mn
Jun 30, 2024 143.00 Mn
Mar 31, 2024 145.00 Mn
Dec 31, 2023 179.00 Mn
Sep 30, 2023 146.00 Mn
Jun 30, 2023 160.00 Mn
Mar 31, 2023 164.00 Mn
Dec 31, 2022 171.00 Mn
Sep 30, 2022 165.00 Mn
Jun 30, 2022 161.00 Mn
Mar 31, 2022 177.00 Mn
Dec 31, 2021 184.00 Mn
Sep 30, 2021 162.00 Mn